WHO - World Health Organization
$20,000,000.00 CAD
- Department
- Global Affairs Canada
- Program
- —
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- October 12, 2021 – March 31, 2023
- Project status
- Closed
- Reference
- CA-3-P009758002
Published purpose
This project aims to advance equitable and affordable access to the most promising COVID-19 treatments in lower-income countries and lower-middle-income countries (LMICs). The project supports Unitaid in securing manufacturing capacity and supply for relevant treatments, including monoclonal antibodies, novel antivirals, and medical oxygen. This project contributes to the Access to COVID-19 Tools (ACT) -– Accelerator Therapeutics Partnership objectives. Project activities include: (1) increasing access to medical oxygen; (2) improving supply security across sub-Saharan Africa through market interventions; and (3) piloting the introduction, feasibility and acceptability of innovations in at least 5 countries. This project represents additional funds provided to a pre-existing project in response to the COVID-19 pandemic. The description and expected results are the same.
In plain English AI-generated
This project funds Unitaid to improve access to COVID-19 treatments, including medical oxygen and antivirals, in lower-income countries, focusing on supply security and piloting innovations in at least five countries.
Category: Foreign Aid Development Primarily funds activity outside Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.